THU0255 The Efficacy of Dmards Combination Therapy Using MTX and Low Dose Tacrolimus Depend on Modulation of MRP2 Expression.
Volume: 72, Issue: Suppl 3, Pages: A251.3 - A252
Published: Jun 1, 2013
Abstract
Background
Methotrexate (MTX) is an anchor drug for the treatment of rheumatoid arthritis (RA) because of efficacy and safety. Although MTX is used in monotherapy generally, combination therapy with biologics or another disease-modifying antirheumatic drugs (DMARDs) is recommended for RA patients refractory to MTX monotherapy. Tacrolimus (TAC) is used as immunosuppressant agent for control of graft rejection in hepatic or renal...Paper Details
Title
THU0255 The Efficacy of Dmards Combination Therapy Using MTX and Low Dose Tacrolimus Depend on Modulation of MRP2 Expression.
Published Date
Jun 1, 2013
Volume
72
Issue
Suppl 3
Pages
A251.3 - A252
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History